Top Markets
Coin of the day
Aelis Farma S.A. Aelis Farma S.A.

Aelis Farma S.A.

AELIS
Clasificación en acciones #30383
Aelis Farma S.A., a French biotechnology company founded in 2013 and... Aelis Farma S.A., a French biotechnology company founded in 2013 and headquartered in Bordeaux, is dedicated to the discovery and development of treatments for brain-related illnesses. The firm's research pipeline primarily focuses on signaling-specific inhibitors that target CB1 receptors. Its leading investigational drug, AEF0117, is currently advancing through Phase 2b clinical trials, designed to alleviate the harmful impacts of excessive cannabis consumption. Furthermore, AEF0217, another key drug candidate, has successfully completed Phase 1 clinical trials, with the goal of addressing cognitive impairments linked to Down syndrome and other similar conditions.
Precio por acción
$1.25
Última sincronización: 2026-08-18
Capitalización bursátil
$17.05M
Cambio (1 día)
-1.50%
Cambio (1 año)
-22.24%
País
FR
Comercio Aelis Farma S.A. (AELIS)

Categoría

Ratio P/S de Aelis Farma S.A. (AELIS)
Ratio P/S al 2026 TTM: 0
Según los informes financieros más recientes y el precio de las acciones de Aelis Farma S.A., el ratio P/S actual (TTM) es 0. Al final de 2026, el ratio P/S era 0.
Historial del ratio P/S de Aelis Farma S.A. desde 2026 hasta 2026
Ratio P/S al final de cada año
Año Ratio P/S Cambiar
Not enough data for the provided dates.
Ratio P/S de empresas similares o competidoras
Empresa Ratio P/S Diferencia del ratio P/S País
10.17 -
US
10.13 -
NL
2.95 -
AU
- -
CH
- -
KR